Although the current avian influenza outbreak began more than two years ago, detections have been made in recent weeks in cattle, cats and large commercial poultry flocks across the country and in Michigan.
Not for public release
This news release is embargoed until 18-Mar-2024 5:00 PM EDT
Released to reporters: 12-Mar-2024 2:00 PM EDT
A reporter's PressPass is required to
access this story until the embargo expires on 18-Mar-2024 5:00 PM EDT
The Newswise PressPass gives verified journalists access to embargoed stories.
Please log in to complete a presspass application.
If you have not yet registered, please Register. When you
fill out the registration form, please identify yourself as a reporter in order to
advance to the presspass application form.
As Canada’s flu season collides with record strep A cases and ongoing COVID-19 concerns, a new study is shedding light on our understanding of respiratory immune responses
Influenza A viruses with induced resistance to a new candidate antiviral drug were found to be impaired in cell culture and weakened in animals, according to a study by researchers in the Center for Translational Antiviral Research at Georgia State University.
Federal officials are describing a ‘tripledemic’ of respiratory infections on the rise. Flu, COVID-19, and RSV are spiking, as expected, as we are in the mid-winter months. Lisa M. Lee, a professor of public health at Virginia Tech, answered questions about factors for concern and the importance of vaccination. Lee is an epidemiologist and bioethicist who has worked in public health and ethics for 25 years, including 14 years with CDC.
New research from Washington University School of Medicine in St. Louis and the Veterans Affairs St. Louis Health Care System comparing the viruses that cause the flu and COVID-19 shows that people hospitalized with seasonal influenza also can suffer long-term, negative health effects, especially involving their lungs and airways. The study also found that in the 18 months after infection, patients hospitalized for either COVID-19 or seasonal influenza faced an increased risk of death, hospital readmission, and other health problems.
Imagine the ability to quickly and accurately diagnose if you are infected with influenza, respiratory syncytial virus (RSV) or COVID-19 with one breath in less than a minute.
Francesca Torriani, MD, infectious disease specialist at UC San Diego Health available to discuss importance of vaccination against influenza.
Not for public release
This news release is embargoed until 27-Nov-2023 5:00 PM EST
Released to reporters: 20-Nov-2023 2:00 PM EST
A reporter's PressPass is required to
access this story until the embargo expires on 27-Nov-2023 5:00 PM EST
The Newswise PressPass gives verified journalists access to embargoed stories.
Please log in to complete a presspass application.
If you have not yet registered, please Register. When you
fill out the registration form, please identify yourself as a reporter in order to
advance to the presspass application form.
Despite the Centers for Disease Control and Prevention warning this year will be potentially dangerous for respiratory illnesses, a third of Americans are not concerned about the threat, according to a new national survey by The Ohio State University Wexner Medical Center.
The current flu season has started later and more gradually than last year, according to William Schaffner, MD, professor of Preventive Medicine at Vanderbilt University Medical Center (VUMC), although cases are expected to begin increasing in November before falling off in March.
Simon Fraser University researchers studying the evolutionary history of flu viruses have found that a new quantitative analysis of how they evolved may help predict future strains.
As the seasons transition from warm fall nights to cool and wintry evenings, children with asthma often experience a rise in wheezing or chest tightness, because weather changes and cold temperatures are often asthma triggers.
The Johns Hopkins Bloomberg School of Public Health is hosting an expert briefing for the media from 2:00 p.m. to 2:30 p.m. EDT, Thursday, October 12, on how to take steps to stay healthy as COVID and RSV cases climb and flu season approaches.
The new COVID-19 EG.5 variant is responsible for around 22% of current cases. The World Health Organization has classified it as a “variant of interest,” meaning countries should monitor it more closely than other strains — and cases have only increased in the past few weeks. Peter Gulick is an expert on infectious diseases, and he provides insight on what this new variant could mean and what you should know.
Cases of COVID-19 are up since this summer, and a new vaccine is available. A Penn State Health infectious disease expert offers the latest on the pandemic.
Researchers from the University of Pittsburgh and the National Institutes of Health (NIH) Vaccine Research Center have developed an improved way to test potential vaccines against bird flu. The report was published this week in the journal iScience.
As cities brace for a confluence of flu, COVID-19, pneumonia, and RSV infections this fall, the American Thoracic Society announced that five new health systems have partnered with the Society to improve vaccination rates.
Researchers from Trinity College Dublin have discovered some new and surprising ways that viral RNA and influenza virus are detected by human lung cells, which has potential implications for treating people affected by such viruses.
St. Jude Children’s Research Hospital scientists found that immune cells present in individuals long before influenza infection predict whether the illness is symptomatic.
Researchers demonstrate that among individuals who were admitted to the hospital with COVID-19 and were discharged alive, the risk of post-discharge death was nearly twice that observed in those who were discharged alive from an influenza-related hospital admission.
Researchers from University of British Columbia and Michigan State University have invented a system that can quickly and inexpensively detect airborne viruses using the same technology that enables high-speed trains.
Given their research indicating public health suffers when a professional sports team makes its home in a new city, West Virginia University economists are asking whether publicly funded subsidies for sports arenas make sense.
Scientists at St. Jude Children’s Research Hospital showed that fixed mutations within a viral population most likely stem from how easy it is to acquire that mutation (i.e., mutation accessibility) rather than just its benefit.
Today, at the 2023 AACC Annual Scientific Meeting & Clinical Lab Expo, scientists will present new data about rates of co-infections with SARS-CoV-2, influenza, and respiratory syncytial virus (RSV) in the United States.
While the incidence of influenza-associated neuropsychiatric events in children in the United States is unknown, the controversy over the use of a common antiviral medication typically administered to treat flu in children has sparked concern among parents and medical professionals alike. The dilemma about whether the treatment causes neuropsychiatric events or if the infection itself is the culprit, led a group of pediatric researchers at Monroe Carell Jr.
A new study in mice suggests that having a common form of the flu during pregnancy may affect the next generation by impairing immune function in the gut. The study is published ahead of print in the American Journal of Physiology-Gastrointestinal and Liver Physiology.
Influenza A is one of two influenza viruses that fuel costly annual flu seasons and is a near constant threat to humans and many other animals. It’s also responsible for occasional pandemics that, like the one in 1918, leave millions dead and wreak havoc on health systems and wider society. Influenza A was first identified as a health threat nearly a century ago, but only in the last decade have scientists identified one of the virus’s key proteins for infiltrating host cells and short-circuiting their defenses.
Researchers from The University of Texas Health Science Center at San Antonio, working with collaborators in five countries, today revealed that the capacity to resist or recover from infections and other sources of inflammatory stress — called “immune resilience” — differs widely among individuals.
A successful long-term experiment with live hogs indicates Nebraska scientists may be another step closer to achieving a safe, long-lasting and potentially universal vaccine against swine flu.
Scientists at St. Jude Children’s Research Hospital have discovered H5N1 avian influenza viruses gained the ability to cause severe disease and target the brain in mammals as they spread across North America.
Title 42, the United States pandemic rule that had been used to immediately deport hundreds of thousands of migrants who crossed the border illegally over the last three years, has expired. Those migrants will have the opportunity to apply for asylum. President Biden's new rules to replace Title 42 are facing legal challenges. Border crossings have already risen sharply, as many migrants attempt to cross before the measure expires on Thursday night. Some have said they worry about tighter controls and uncertainty ahead. Immigration is once again a major focus of the media as we examine the humanitarian, political, and public health issues migrants must go through.
Researcher will discuss the study which involved a sleeping aid known as suvorexant that is already approved by the Food and Drug Administration (FDA) for insomnia, hints at the potential of sleep medications to slow or stop the progression of Alzheimer’s disease.
After helping to develop and test new mRNA technologies for COVID-19 vaccines, University of Maryland School of Medicine (UMSOM) researchers and scientists are turning their attention to utilizing this innovative technology to ward off other infectious diseases like malaria and influenza.